{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:19:27Z","timestamp":1792790367096,"version":"4.5.0"},"posted":{"date-parts":[[2026,9,30]]},"group-title":"Cancer Biology","reference-count":42,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"name":"National Cancer Institute Grant","award":["R01CA233959"],"award-info":[{"award-number":["R01CA233959"]}]},{"name":"NIGMS","award":["R35GM150992"],"award-info":[{"award-number":["R35GM150992"]}],"id":[{"id":"https:\/\/ror.org\/04q48ey07","id-type":"ROR","asserted-by":"crossref"}]},{"name":"2026 UVMCC Pilot Project"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Therapeutic resistance remains a barrier to durable treatment of colorectal cancer (CRC), highlighting the need to identify vulnerabilities in resistant tumor cells. REV7 (MAD2L2) is a multifunctional genome-maintenance protein with established roles in REV3-dependent translesion synthesis (TLS) as well as mitotic progression, spindle organization, and chromosome segregation. Although perturbing REV7-dependent DNA damage tolerance has emerged as a strategy to overcome chemoresistance, whether pharmacologic targeting of REV7 exposes vulnerabilities to mitotic disruption remains poorly understood. Here, we investigated the REV7-targeting small-molecule inhibitor C10, which disrupts the REV7\u2013REV3 interaction, and found that C10 sensitized HCT116 and HT-29 CRC cells to the microtubule-disrupting agent colchicine, resulting in markedly reduced clonogenic survival. In contrast, C10 did not substantially enhance sensitivity to cisplatin. Genetic loss of REV7 similarly increased sensitivity to colchicine, independently supporting a REV7-dependent vulnerability to microtubule disruption. Combined C10 and colchicine treatment was associated with pronounced alterations in mitotic and post-mitotic nuclear morphology, including condensed\/mitotic-like and multinucleated configurations, and increased micronucleus formation. In HT-29 cells, combined treatment also increased the frequency of cells containing multiple \u03b3-tubulin-positive foci, consistent with disrupted centrosome-associated organization. Together, these findings support a model in which REV7-dependent functions contribute to cellular tolerance and recovery from microtubule-mediated mitotic stress, whereas REV7\u2013REV3 disruption renders CRC cells vulnerable to mitotic perturbation. This study broadens the potential consequences of targeting REV7 beyond its canonical role in TLS and suggests that combining REV7-directed inhibition with mitotic perturbation warrants further investigation as a therapeutic strategy in CRC and potentially other cancers.<\/jats:p>","DOI":"10.64898\/2026.09.29.755408","type":"posted-content","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:10:17Z","timestamp":1790788217000},"source":"Crossref","is-referenced-by-count":0,"title":["Targeting REV7 exposes a mitotic vulnerability in colorectal cancer cells"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6084-5787","authenticated-orcid":false,"given":"Madison","family":"Guyette","sequence":"first","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, U.S.A. 05405"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sombodhi","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, U.S.A. 05405"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kothandaraman","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, U.S.A. 05405"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vihit","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, U.S.A. 05405"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Crompton","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, U.S.A. 05405"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Boyle","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, U.S.A. 05405"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Harrahill","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, U.S.A. 06269"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Ramsey","sequence":"additional","affiliation":[{"name":"Larner College of Medicine, University of Vermont, Burlington, Vermont, U.S.A. 05405"},{"name":"Department of Biochemistry, University of Vermont, Burlington, Vermont, U.S.A. 05405"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry M.","family":"Korzhnev","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, Connecticut, U.S.A 06030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Kyle","family":"Hadden","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, U.S.A. 06269"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6556-9423","authenticated-orcid":false,"given":"Nimrat","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, U.S.A. 05405"},{"name":"Larner College of Medicine, University of Vermont, Burlington, Vermont, U.S.A. 05405"},{"name":"University of Vermont Cancer Center, University of Vermont, Burlington, Vermont, U.S.A. 05405"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026100321000551000_2026.09.29.755408v1.1","first-page":"1516165","article-title":"REV7: a small but mighty regulator of genome maintenance and cancer development","volume":"14","year":"2024","journal-title":"Front Oncol"},{"key":"2026100321000551000_2026.09.29.755408v1.2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006842"},{"key":"2026100321000551000_2026.09.29.755408v1.3","doi-asserted-by":"publisher","DOI":"10.1002\/em.22087"},{"issue":"1","key":"2026100321000551000_2026.09.29.755408v1.4","first-page":"e52542","article-title":"The Immunohistochemical Expression of REV-7 in Various Human Cancer Pathology Specimens: A Systematic Review","volume":"16","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"2026100321000551000_2026.09.29.755408v1.5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000549588","article-title":"REV7 Expression Is Associated with Tumor Cell Growth and Cisplatin Resistance in Gallbladder Adenocarcinoma","volume":"93","year":"2026","journal-title":"Pathobiology"},{"issue":"1","key":"2026100321000551000_2026.09.29.755408v1.6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s12672-025-02224-9","article-title":"Expression of REV7 has prognostic significance in cervical cancer treated with intensity-modulated radiation therapy","volume":"16","year":"2025","journal-title":"Discov Oncol"},{"key":"2026100321000551000_2026.09.29.755408v1.7","doi-asserted-by":"crossref","first-page":"155779","DOI":"10.1016\/j.prp.2024.155779","article-title":"Elevated expression of REV7 correlates with poor prognosis in lung adenocarcinoma and its inactivation in carcinoma cells enhances chemosensitivity","volume":"266","year":"2025","journal-title":"Pathol Res Pract"},{"issue":"4","key":"2026100321000551000_2026.09.29.755408v1.8","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/hed.28015","article-title":"Significance of REV7 Expression in p16-Negative Oropharyngeal Squamous Cell Carcinoma","volume":"47","year":"2025","journal-title":"Head Neck"},{"issue":"1","key":"2026100321000551000_2026.09.29.755408v1.9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/s12935-020-01668-z","article-title":"Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer","volume":"20","year":"2020","journal-title":"Cancer Cell Int"},{"issue":"18","key":"2026100321000551000_2026.09.29.755408v1.10","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1016\/j.bmc.2016.07.026","article-title":"Identification of the first small-molecule inhibitor of the REV7 DNA repair protein interaction","volume":"24","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"2026100321000551000_2026.09.29.755408v1.11","doi-asserted-by":"crossref","first-page":"1859193","DOI":"10.3389\/fcell.2026.1859193","article-title":"Targeting MAD2L2-dependent translesion synthesis impairs DNA damage tolerance and enhances cellular response to cisplatin","volume":"14","year":"2026","journal-title":"Front Cell Dev Biol"},{"issue":"16","key":"2026100321000551000_2026.09.29.755408v1.12","doi-asserted-by":"crossref","first-page":"e70427","DOI":"10.1002\/cmdc.70427","article-title":"Docking-Based Virtual Screening Identifies a Small-Molecule Inhibitor of the Translesion Synthesis REV7\/REV3 Protein-Protein Interaction","volume":"21","year":"2026","journal-title":"ChemMedChem"},{"key":"2026100321000551000_2026.09.29.755408v1.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0340-7"},{"key":"2026100321000551000_2026.09.29.755408v1.14","doi-asserted-by":"publisher","DOI":"10.4161\/cc.23214"},{"key":"2026100321000551000_2026.09.29.755408v1.15","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2015.1120922"},{"key":"2026100321000551000_2026.09.29.755408v1.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00709-005-0137-z"},{"key":"2026100321000551000_2026.09.29.755408v1.17","doi-asserted-by":"publisher","DOI":"10.1101\/gad.897901"},{"key":"2026100321000551000_2026.09.29.755408v1.18","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201591697"},{"key":"2026100321000551000_2026.09.29.755408v1.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007020"},{"issue":"4","key":"2026100321000551000_2026.09.29.755408v1.20","doi-asserted-by":"crossref","first-page":"115431","DOI":"10.1016\/j.celrep.2025.115431","article-title":"REV7 functions with REV3 as a checkpoint protein delaying mitotic entry until DNA replication is completed","volume":"44","year":"2025","journal-title":"Cell Rep"},{"key":"2026100321000551000_2026.09.29.755408v1.21","doi-asserted-by":"publisher","DOI":"10.1002\/med.20097"},{"key":"2026100321000551000_2026.09.29.755408v1.22","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.99.3.1066"},{"key":"2026100321000551000_2026.09.29.755408v1.23","doi-asserted-by":"crossref","unstructured":"Heck KA , Lindholm HT , Niederdorfer B , Tsirvouli E , Kuiper M , Flobak A , et al. Characterisation of Colorectal Cancer Cell Lines through Proteomic Profiling of Their Extracellular Vesicles. Proteomes. 2023;11(1).","DOI":"10.3390\/proteomes11010003"},{"key":"2026100321000551000_2026.09.29.755408v1.24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0002"},{"key":"2026100321000551000_2026.09.29.755408v1.25","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5021"},{"key":"2026100321000551000_2026.09.29.755408v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/386623a0"},{"key":"2026100321000551000_2026.09.29.755408v1.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-005-0050-3"},{"key":"2026100321000551000_2026.09.29.755408v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2011.06.016"},{"key":"2026100321000551000_2026.09.29.755408v1.29","doi-asserted-by":"publisher","DOI":"10.1126\/science.8484122"},{"key":"2026100321000551000_2026.09.29.755408v1.30","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0147"},{"key":"2026100321000551000_2026.09.29.755408v1.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2020.11.003"},{"key":"2026100321000551000_2026.09.29.755408v1.32","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-2-30"},{"key":"2026100321000551000_2026.09.29.755408v1.33","doi-asserted-by":"publisher","DOI":"10.1007\/s10577-015-9505-5"},{"key":"2026100321000551000_2026.09.29.755408v1.34","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.7.1122"},{"key":"2026100321000551000_2026.09.29.755408v1.35","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P"},{"key":"2026100321000551000_2026.09.29.755408v1.36","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2023-0025"},{"key":"2026100321000551000_2026.09.29.755408v1.37","doi-asserted-by":"crossref","unstructured":"Piemonte KM , Anstine LJ , Keri RA . Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer. Endocrinology. 2021;162(12).","DOI":"10.1210\/endocr\/bqab208"},{"key":"2026100321000551000_2026.09.29.755408v1.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(95)00276-4"},{"key":"2026100321000551000_2026.09.29.755408v1.39","doi-asserted-by":"publisher","DOI":"10.1002\/em.20532"},{"key":"2026100321000551000_2026.09.29.755408v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.164"},{"key":"2026100321000551000_2026.09.29.755408v1.41","doi-asserted-by":"publisher","DOI":"10.1038\/s44319-024-00260-0"},{"key":"2026100321000551000_2026.09.29.755408v1.42","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E18-10-0651"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.09.29.755408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:00:17Z","timestamp":1791086417000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.09.29.755408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":42,"URL":"https:\/\/doi.org\/10.64898\/2026.09.29.755408","relation":{},"subject":[],"published":{"date-parts":[[2026,9,30]]},"subtype":"preprint"}}